$QCLS News

Q/C Technologies Rolls Out New Initiative To Design, Prototype Proprietary Optical Processing Unit

Martin Shkreli's New Computing Firm Is Betting It Can Upend Nvidia's Business Model

12 Health Care Stocks Moving In Friday's Intraday Session

Q/C Technologies To Offer Securities Up To $100M

Q/C Technologies Appoints AI Systems Leader Chelsea Voss to Board of Directors

Martin Shkreli Takes Position In QCLS, Leveraging Microsoft's Optical Computing Roadmap For Bull Case: '$100 Is My Near-Term Target'

Q/C Technologies Shares Resume Trade Following Circuit Breaker Halt

Q/C Technologies Shares Resume Trade Following Circuit Breaker Halt

Q/C Technologies Q3 EPS $(2.50) Up From $(107.62) YoY

Q/C Technologies Announces Collaboration With LightSolver; Q/C To Adapt LightSolver's Laser Processing Unit Technology

James Altucher Posts On X "A legit new player in quantum stocks. $QCLS"

Q/C Technologies Appoints Technion Professor Dr. Steven Frankel as Senior Quantum Advisor to Advance Photonic and Quantum-Class Computing Initiatives

Trending Quantum Stocks—Rigetti And D-Wave Are Popping

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance

TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation

TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease

TNF Pharmaceuticals and Renova Health Report Positive Results in Identifying Targets for Treating TNF-Driven Inflammation in Patients Receiving GLP-1 Agonists

TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug Development

TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society’s Spring Meeting 2025